1-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1,4-DIAZEPANE, 95%, 1g

(S)-tert-butyl 4-(4-(2-methoxy-2-oxoethyl)benzyl)-2-methylpiperazine-1-carboxylate, 95%, 50mg

GC capillary column ROTI®Cap-5, 50 m, 0.53 mm, 5.00 µm, 1 Piece(s)

Lutetium oxalate hydrate 99.9% 5 g

Methyl 2-(4-bromo-3-fluorophenyl)acetate, 97%, 1g

2,3-Dihydroxy-N,N,N-trimethylpropan-1-aminium chloride, 97.0%, 10g

Weighing pan ROTILABO® hexagonal, 9 ml, 500 Piece(s)

1-(1,3-benzodioxol-5-ylmethyl)-1H-imidazole-2-thiol, 95.0%, 250mg

5-Chloro-2-methylpyrazolo[1,5-a]quinazoline, 95%, 250mg

(2-Bromo-5-fluoropyridin-4-yl)methanol, 97%, 250mg

1-(4-chloro-3-nitrobenzoyl)-3-methylpiperazine, 95.0%, 1g

Potassium formate, min. 98%, for synthesis, 250 g, plastic packaging.

(6-Ethoxy-5-methylpyridin-3-yl)boronic acid, 98%, 1g